123
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Humanin inhibits lymphatic endothelial cells dysfunction to alleviate myocardial infarction-reperfusion injury via BNIP3-mediated mitophagy

, , , &
Pages 180-193 | Received 11 Apr 2023, Accepted 20 Feb 2024, Published online: 27 Mar 2024

References

  • Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet. 2006;367(9524):1747–1757. doi:10.1016/S0140-6736(06)68770-9.
  • Rao SV, Kaul P, Newby LK, et al. Poverty, process of care, and outcome in acute coronary syndromes. J Am Coll Cardiol. 2003;41(11):1948–1954. doi:10.1016/s0735-1097(03)00402-9.
  • Galiuto L, DeMaria AN, Iliceto S. Microvascular damage during myocardial ischemia-reperfusion: pathophysiology, clinical implications and potential therapeutic approach evaluated by myocardial contrast echocardiography. Ital Heart J. 2000;1(2):108–116.
  • Eefting F, Rensing B, Wigman J, et al. Role of apoptosis in reperfusion injury. Cardiovasc Res. 2004;61(3):414–426. doi:10.1016/j.cardiores.2003.12.023.
  • Mathur A, Martin JF. Stem cells and repair of the heart. Lancet. 2004;364(9429):183–192. doi:10.1016/S0140-6736(04)16632-4.
  • Alitalo K. The lymphatic vasculature in disease. Nat Med. 2011;17(11):1371–1380. doi:10.1038/nm.2545.
  • Henri O, Pouehe C, Houssari M, et al. Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction. Circulation. 2016;133(15):1484–1497; discussion 1497. doi:10.1161/CIRCULATIONAHA.115.020143.
  • Tatin F, Renaud-Gabardos E, Godet A-C, et al. Apelin modulates pathological remodeling of lymphatic endothelium after myocardial infarction. JCI Insight. 2017;2(12):e93887. 93887. doi:10.1172/jci.insight.93887.
  • Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and mitophagy in cardiovascular disease. Circ Res. 2017;120(11):1812–1824. doi:10.1161/CIRCRESAHA.117.311082.
  • Palikaras K, Lionaki E, Tavernarakis N. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature. 2015;521(7553):525–528. doi:10.1038/nature14300.
  • Yang M, Linn BS, Zhang Y, et al. Mitophagy and mitochondrial integrity in cardiac ischemia-reperfusion injury. Biochim Biophys Acta Mol Basis Dis. 2019;1865(9):2293–2302. doi:10.1016/j.bbadis.2019.05.007.
  • Zhang Y, Wang Y, Xu J, et al. Melatonin attenuates myocardial ischemia-reperfusion injury via improving mitochondrial fusion/mitophagy and activating the AMPK-OPA1 signaling pathways. J Pineal Res. 2019;66:e12542.
  • Guan L, Che Z, Meng X, et al. MCU up-regulation contributes to myocardial ischemia-reperfusion injury through calpain/OPA-1-mediated mitochondrial fusion/mitophagy inhibition. J Cell Mol Med. 2019;23(11):7830–7843. doi:10.1111/jcmm.14662.
  • Jin Q, Li R, Hu N, et al. DUSP1 alleviates cardiac ischemia/reperfusion injury by suppressing the mff-required mitochondrial fission and Bnip3-related mitophagy via the JNK pathways. Redox Biol. 2018;14:576–587. doi:10.1016/j.redox.2017.11.004.
  • Jin H, Zhu Y, Li Y, et al. BDNF-mediated mitophagy alleviates high-glucose-induced brain microvascular endothelial cell injury. Apoptosis. 2019;24(5-6):511–528. doi:10.1007/s10495-019-01535-x.
  • Piao S, Nagar H, Kim S, et al. CRIF1 deficiency induced mitophagy via p66shc-regulated ROS in endothelial cells. Biochem Biophys Res Commun. 2020;522(4):869–875. doi:10.1016/j.bbrc.2019.11.109.
  • Chai G-S, Duan D-X, Ma R-H, et al. Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats. Neurosci Bull. 2014;30(6):923–935. doi:10.1007/s12264-014-1479-3.
  • Xu X, Chua CC, Gao J, et al. Humanin is a novel neuroprotective agent against stroke. Stroke. 2006;37(10):2613–2619. doi:10.1161/01.STR.0000242772.94277.1f.
  • Yang X, Zhang H, Wu J, et al. Humanin attenuates NMDA-induced excitotoxicity by inhibiting ROS-dependent JNK/p38 MAPK pathway. IJMS. 2018;19(10):2982. doi:10.3390/ijms19102982.
  • Thummasorn S, Apaijai N, Kerdphoo S, et al. Humanin exerts cardioprotection against cardiac ischemia/reperfusion injury through attenuation of mitochondrial dysfunction. Cardiovasc Ther. 2016;34(6):404–414. doi:10.1111/1755-5922.12210.
  • Feng D, Wang B, Wang L, et al. Pre-ischemia melatonin treatment alleviated acute neuronal injury after ischemic stroke by inhibiting endoplasmic reticulum stress-dependent autophagy via PERK and IRE1 signalings. J Pineal Res. 2017;62(3). doi:10.1111/jpi.12395.
  • Vongsfak J, Pratchayasakul W, Apaijai N, et al. The alterations in mitochondrial dynamics following cerebral ischemia/reperfusion injury. Antioxidants (Basel). 2021;10(9):1384. doi:10.3390/antiox10091384.
  • Ren N, Wang M. microRNA-212-induced protection of the heart against myocardial infarction occurs via the interplay between AQP9 and PI3K/akt signaling pathway. Exp Cell Res. 2018;370(2):531–541. doi:10.1016/j.yexcr.2018.07.018.
  • Meloni M, Marchetti M, Garner K, et al. Local inhibition of microRNA-24 improves reparative angiogenesis and left ventricle remodeling and function in mice with myocardial infarction. Mol Ther. 2013;21(7):1390–1402. doi:10.1038/mt.2013.89.
  • Lu C, Wang X, Ha T, et al. Attenuation of cardiac dysfunction and remodeling of myocardial infarction by microRNA-130a are mediated by suppression of PTEN and activation of PI3K dependent signaling. J Mol Cell Cardiol. 2015;89(Pt A):87–97. doi:10.1016/j.yjmcc.2015.10.011.
  • Dutta P, Nahrendorf M. Monocytes in myocardial infarction. Arterioscler Thromb Vasc Biol. 2015;35(5):1066–1070. doi:10.1161/ATVBAHA.114.304652.
  • Sala V, Crepaldi T. Novel therapy for myocardial infarction: can HGF/met be beneficial? Cell Mol Life Sci. 2011;68(10):1703–1717. doi:10.1007/s00018-011-0633-6.
  • Mezzaroma E, Toldo S, Farkas D, et al. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A. 2011;108(49):19725–19730. doi:10.1073/pnas.1108586108.
  • Huang S, Frangogiannis NG. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges. Br J Pharmacol. 2018;175(9):1377–1400. doi:10.1111/bph.14155.
  • Chung CH, Bretherton B, Zainalabidin S, et al. Mediation of cardiac macrophage activity via auricular vagal nerve stimulation ameliorates cardiac ischemia/reperfusion injury. Front Neurosci. 2020;14:906. doi:10.3389/fnins.2020.00906.
  • Aspelund A, Robciuc MR, Karaman S, et al. Lymphatic system in cardiovascular medicine. Circ Res. 2016;118(3):515–530. doi:10.1161/CIRCRESAHA.115.306544.
  • Bradham RR, Parker EF. The cardiac lymphatics. Ann Thorac Surg. 1973;15(5):526–535. doi:10.1016/s0003-4975(10)65339-8.
  • Harris NR, Nielsen NR, Pawlak JB, et al. VE-cadherin is required for cardiac lymphatic maintenance and signaling. Circ Res. 2022;130(1):5–23. doi:10.1161/CIRCRESAHA.121.318852.
  • Vieira JM, Norman S, Villa Del Campo C, et al. The cardiac lymphatic system stimulates resolution of inflammation following myocardial infarction. J Clin Invest. 2018;128(8):3402–3412. doi:10.1172/JCI97192.
  • Klein LE, Cui L, Gong Z, et al. A humanin analog decreases oxidative stress and preserves mitochondrial integrity in cardiac myoblasts. Biochem Biophys Res Commun. 2013;440(2):197–203. doi:10.1016/j.bbrc.2013.08.055.
  • Nantsupawat T, Wongcharoen W, Chattipakorn SC, et al. Effects of metformin on atrial and ventricular arrhythmias: evidence from cell to patient. Cardiovasc Diabetol. 2020;19(1):198. doi:10.1186/s12933-020-01176-4.
  • Ashrafi G, Schwarz TL. The pathways of mitophagy for quality control and clearance of mitochondria. Cell Death Differ. 2013;20(1):31–42. doi:10.1038/cdd.2012.81.
  • Hashimoto Y, Ito Y, Niikura T, et al. Mechanisms of neuroprotection by a novel rescue factor humanin from swedish mutant amyloid precursor protein. Biochem Biophys Res Commun. 2001;283(2):460–468. doi:10.1006/bbrc.2001.4765.
  • Hashimoto Y, Niikura T, Tajima H, et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer’s disease genes and abeta. Proc Natl Acad Sci U S A. 2001;98(11):6336–6341. doi:10.1073/pnas.101133498.
  • Muzumdar RH, Huffman DM, Atzmon G, et al. Humanin: a novel Central regulator of peripheral insulin action. PLoS One. 2009;4(7):e6334. doi:10.1371/journal.pone.0006334.
  • Maximov V, Martynenko A, Hunsmann G, et al. Mitochondrial 16S rRNA gene encodes a functional peptide, a potential drug for Alzheimer’s disease and target for cancer therapy. Med Hypotheses. 2002;59(6):670–673. doi:10.1016/s0306-9877(02)00223-2.
  • Yamagishi Y, Hashimoto Y, Niikura T, et al. Identification of essential amino acids in humanin, a neuroprotective factor against Alzheimer’s disease-relevant insults. Peptides. 2003;24(4):585–595. doi:10.1016/s0196-9781(03)00106-2.
  • Guo B, Zhai D, Cabezas E, et al. Humanin peptide suppresses apoptosis by interfering with bax activation. Nature. 2003;423(6938):456–461. doi:10.1038/nature01627.
  • Paharkova V, Alvarez G, Nakamura H, et al. Rat humanin is encoded and translated in mitochondria and is localized to the mitochondrial compartment where it regulates ROS production. Mol Cell Endocrinol. 2015;413:96–100. doi:10.1016/j.mce.2015.06.015.
  • Thummasorn S, Shinlapawittayatorn K, Khamseekaew J, et al. Humanin directly protects cardiac mitochondria against dysfunction initiated by oxidative stress by decreasing complex I activity. Mitochondrion. 2018;38:31–40. doi:10.1016/j.mito.2017.08.001.
  • Qin Q, Mehta H, Yen K, et al. Chronic treatment with the mitochondrial peptide humanin prevents age-related myocardial fibrosis in mice. Am J Physiol Heart Circ Physiol. 2018;315(5):H1127–H1136. doi:10.1152/ajpheart.00685.2017.
  • Kumfu S, Charununtakorn ST, Jaiwongkam T, et al. Humanin prevents brain mitochondrial dysfunction in a cardiac ischaemia-reperfusion injury model. Exp Physiol. 2016;101(6):697–707. doi:10.1113/EP085749.
  • Muzumdar RH, Huffman DM, Calvert JW, et al. Acute humanin therapy attenuates myocardial ischemia and reperfusion injury in mice. Arterioscler Thromb Vasc Biol. 2010;30(10):1940–1948. doi:10.1161/ATVBAHA.110.205997.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.